Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Reynolds Consumer Products Q3 2026: Net Income $58M

Reynolds Consumer Products Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting third-quarter and nine-month financial results.

Nitish Kishor | 04 November 2026

Plumas Bancorp Posts $31.1M Net Income for Nine Months Ended Sept 30, 2026

Plumas Bancorp filed a Form 10-Q with the SEC on November 4, 2026, covering the quarterly and nine-month periods ended September 30, 2026, reporting net income of $31,108 thousand for the nine months ended September 30, 2026.

Manish Choudhary | 04 November 2026

Actinium Releases Three Iomab-ACT Abstracts for ASH 2026

Actinium Pharmaceuticals, Inc. filed an 8-K on November 4, 2026, announcing the release of three abstracts for the 68th American Society of Hematology Annual Meeting covering clinical findings for Iomab-ACT as a conditioning agent before CAR T-cell therapy and allogeneic stem cell transplantation.

Shwetambri Chauhan | 04 November 2026

Royalty Pharma Q3 2026: 445M Shares Outstanding at Oct 30

Royalty Pharma plc filed its quarterly report on Form 10-Q with the SEC for the three and nine months ended September 30, 2026, disclosing condensed consolidated financial statements and related disclosures as of that period.

Aakashdeep | 04 November 2026

Actimab-A Long-Term Safety Data Headed to ASH 2026

Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) announced on November 4, 2026 that an abstract evaluating long-term safety and tolerability of Actimab-A (lintuzumab-Ac225) in combination with CLAG-M intensive salvage chemotherapy in relapsed or refractory acute myeloid leukemia patients will be presented at the 2026 American Society …

Anjali Anand | 04 November 2026

Charles River Labs Files Q3 2026 10-Q: 47.9M Shares Outstanding

Charles River Laboratories International, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the fiscal quarter ended September 26, 2026.

Vinay Lochav | 04 November 2026

Luxfer Shareholders Approve $17.37 Wynnchurch Buyout

Luxfer Holdings PLC filed a Form 8-K on November 4, 2026, disclosing that shareholders approved the proposed acquisition by Double Eagle Acquisition Buyer, Inc., a holding company owned by funds managed by Wynnchurch Capital, L.P., at a cash consideration of $17.37 per ordinary share.

Aditi Sarkar | 04 November 2026

AeroVironment Raises Revolving Credit Facility to $450M

AeroVironment, Inc. filed a Form 8-K on November 4, 2026, disclosing that it entered into a Sixth Amendment to its Credit Agreement on October 30, 2026, increasing its aggregate revolving commitments by $100 million and adding BMO Bank N.A. as a new lender.

Aditi Sarkar | 04 November 2026

Penguin Solutions to Sell Cree LED Business to Transom Capital

Penguin Solutions, Inc. filed an 8-K on November 4, 2026, disclosing that it entered into an Equity Purchase Agreement on November 3, 2026, to sell its Cree LED business, which comprises its Optimized LED segment, to Transom Crystal AcquireCo, LLC, an affiliate of Transom …

Shwetambri Chauhan | 04 November 2026

Lyell Immunopharma Prices $80M Private Placement at $10.77

Lyell Immunopharma, Inc. filed a Form 8-K with the SEC on November 4, 2026, disclosing a Securities Purchase Agreement dated November 3, 2026, to sell 7,428,040 shares of common stock in a private placement expected to generate approximately $80.0 million in gross proceeds.

Aakashdeep | 04 November 2026
Support

Hi! How can we help you today?

Loading…